OCT4-induced oligodendrocyte progenitor cells promote remyelination and ameliorate disease
Abstract The generation of human oligodendrocyte progenitor cells (OPCs) may be therapeutically valuable for human demyelinating diseases such as multiple sclerosis. Here, we report the direct reprogramming of human somatic cells into expandable induced OPCs (iOPCs) using a combination of OCT4 and a...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | npj Regenerative Medicine |
Online Access: | https://doi.org/10.1038/s41536-021-00199-z |